GSK360A is a novel inhibitor of prolyl hydroxylase (PHD) domain-containing enzyme. References: Zhou J, Li J, Rosenbaum DM, Zhuang J, Poon C, Qin P, Rivera K, Lepore J, Willette RN, Hu E, Barone FC. The prolyl 4-hydroxylase inhibitor GSK360A decreases post-stroke brain injury and sensory, motor, and cognitive behavioral deficits. PLoS One. 2017 Sep 7;12(9):e0184049. doi: 10.1371/journal.pone.0184049. eCollection 2017. PubMed PMID: 28880966; PubMed Central PMCID: PMC5589177.

纯度：≥98%

CAS：931399-19-8